Nippon Kayaku Of Japan, Teva-Kowa Join In Blood Cell Generic
This article was originally published in PharmAsia News
Executive Summary
Japan's Teva-Kowa Pharma and Nippon Kayaku have agreed on joint development of a generic product to restore white blood cells destroyed by chemotherapy